glipiZIDE — Class II drug recall D-0202-2025
Terminated recall by Amerisource Health Services LLC, reported 2025-01-22, distributed nationwide. Failed Dissolution Specifications:
| Recall number | D-0202-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amerisource Health Services LLC, Columbus, OH, United States |
| Recall initiated | 2024-12-17 |
| Classified | 2025-01-16 |
| Reported by FDA | 2025-01-22 |
| Terminated | 2026-04-16 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 60687-0480-11, 60687-0480-21 |
| Lot numbers | 1012910 |
| Expiration dates | 2025-04-30 |
Product
glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
Reason for recall
Failed Dissolution Specifications:
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0202-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.